Results 141 to 150 of about 7,425 (188)
The effects of increasing and decreasing dopamine on inhibition of return: a psychopharmacological investigation. [PDF]
Exp Brain ResWhitaker GA +6 more
europepmc +1 more source
Recurrent nasal bleed as initial presenting complaint: a rare complication of giant prolactinoma in a 39-year-old. [PDF]
Ann Med Surg (Lond)Fahim W +5 more
europepmc +1 more source
What We (Don't) Know About Lactation in Heritable Aortic Diseases. [PDF]
JACC AdvKilkenny K +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Expert Opinion on Pharmacotherapy, 2000
Cabergoline (CAB) (1-[(6-allelylergolin-8 beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethyl-urea) is an ergoline derivative with potent, selective and long-lasting inhibitory activity on prolactin (PRL) secretion acting on dopamine receptors present in pituitary lactotrophes.
Annamaria Colao +2 more
exaly +4 more sources
Cabergoline (CAB) (1-[(6-allelylergolin-8 beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethyl-urea) is an ergoline derivative with potent, selective and long-lasting inhibitory activity on prolactin (PRL) secretion acting on dopamine receptors present in pituitary lactotrophes.
Annamaria Colao +2 more
exaly +4 more sources
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea
New England Journal of Medicine, 1994 Cabergoline is a long-acting dopamine-agonist drug that suppresses prolactin secretion and restores gonadal function in women with hyperprolactinemic amenorrhea.
Jonathan Webster, M F Scanlon, J Webster
exaly +4 more sources
Biological Psychiatry, 2009 Background: Cabergoline is an ergotamine derivative that increases the expression of glial cell line-derived neurotrophic factor (GDNF) in vitro. We recently showed that GDNF in the ventral tegmental area (VTA) reduces the motivation to consume alcohol ...
Dorit Ron +2 more
exaly +2 more sources